These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 14572203

  • 1. More on the reliability of the microparticle enzyme immunoassay (MEIA) for therapeutic tacrolimus monitoring.
    Hermida J, Tutor JC.
    Clin Lab; 2003; 49(9-10):471-4. PubMed ID: 14572203
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I, Zochowska D, Sanko-Resmer J, Matuszewicz D, Paczek L.
    Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
    [Abstract] [Full Text] [Related]

  • 3. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS, Taylor PJ, Salm P, Morris RG.
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [Abstract] [Full Text] [Related]

  • 4. Effect of the hematocrit and its correction on the relationship between blood tacrolimus concentrations obtained using the microparticle enzyme immunoassay (MEIA) and enzyme multiplied immunoassay technique (EMIT).
    Bouzas L, Ortega FJ, Casado P, Arranz MI, Carcas A, Tutor JC.
    Clin Lab; 2007 Oct; 53(9-12):591-6. PubMed ID: 18257466
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcomes of renal transplantation using liquid chromatographic monitoring of tacrolimus.
    Borrows R, Chusney G, Loucaidou M, James A, Stichbury J, Van Tromp J, Cairns T, Griffith M, Hakim N, McLean A, Palmer A, Papalois V, Taube D.
    Ther Drug Monit; 2006 Apr; 28(2):269-73. PubMed ID: 16628143
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of hematocrit interference in the tacrolimus II microparticle enzyme immunoassay: a tentative approach.
    Hermida J, Fernández MC, Tutor JC.
    Clin Lab; 2005 Apr; 51(1-2):43-5. PubMed ID: 15719703
    [Abstract] [Full Text] [Related]

  • 7. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH, Ozdem S, Caglar S, Tuncer M, Gurkan A, Yucetin L, Senol Y, Demirbas A, Gultekin M, Ersoy FF, Akaydin M.
    Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
    [Abstract] [Full Text] [Related]

  • 8. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
    Ju MK, Chang HK, Kim HJ, Huh KH, Ahn HJ, Kim MS, Kim SI, Kim YS.
    Transplant Proc; 2008 Dec; 40(10):3673-8. PubMed ID: 19100463
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
    Akbas SH, Yavuz A, Tuncer M, Yurdakonar E, Akcit F, Gurkan A, Demirbas A, Gultekin M, Ersoy F, Akaydin M.
    Transplant Proc; 2004 Dec; 36(1):86-8. PubMed ID: 15013308
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
    Marubashi S, Nagano H, Kobayashi S, Eguchi H, Takeda Y, Tanemura M, Umeshita K, Monden M, Doki Y, Mori M.
    J Clin Pharmacol; 2010 Jun; 50(6):705-9. PubMed ID: 20097937
    [Abstract] [Full Text] [Related]

  • 11. Preliminary evaluation of the new TACR flex method versus MEIA method in the therapeutic monitoring of tacrolimus in organ transplantation.
    Bachetoni A, Mariani P, D'Alessandro M, Baiano V, Appodia C, Collepardo D, Berloco P.
    Transplant Proc; 2007 Jun; 39(6):2008-9. PubMed ID: 17692678
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus monitoring in renal transplantation: a comparison between high-performance liquid chromatography and immunoassay.
    Borrows R, Chusney G, Loucaidou M, Singh S, James A, Stichbury J, Van Tromp J, Cairns T, Griffith M, Hakim N, McLean A, Palmer A, Papalois V, Taube D.
    Transplant Proc; 2005 May; 37(4):1733-5. PubMed ID: 15919448
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C, Guinedor A, Barau C, Gozalo C, Grimbert P, Duvoux C, Furlan V, Massias L, Hulin A.
    J Pharm Biomed Anal; 2010 Dec 01; 53(4):997-1002. PubMed ID: 20674215
    [Abstract] [Full Text] [Related]

  • 14. Comparison of blood tacrolimus concentrations in liver and kidney transplant recipients using ACMIA and MEIA immunoassays.
    Freire A, Hermida J, Tutor JC.
    Ups J Med Sci; 2008 Dec 01; 113(1):103-10. PubMed ID: 18521804
    [Abstract] [Full Text] [Related]

  • 15. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
    Braun F, Lorf T, Schütz E, Christians U, Grupp C, Sattler B, Canelo R, Sewing KF, Armstrong VW, Oellerich M, Ringe B.
    Transplant Proc; 1996 Dec 01; 28(6):3175-6. PubMed ID: 8962231
    [No Abstract] [Full Text] [Related]

  • 16. High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants.
    Salm P, Taylor PJ, Clark A, Balderson GA, Grygotis A, Norris RL, Lynch SV, Shaw LM, Pond SM.
    Ther Drug Monit; 1997 Dec 01; 19(6):694-700. PubMed ID: 9421113
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the reintroduced MEIA assay with HPLC-MS/MS for the determination of whole-blood sirolimus from transplant recipients.
    Morris RG, Salm P, Taylor PJ, Wicks FA, Theodossi A.
    Ther Drug Monit; 2006 Apr 01; 28(2):164-8. PubMed ID: 16628125
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of a new immunoassay to measure sirolimus blood concentrations compared to a tandem mass-spectrometric chromatographic analysis.
    Fillée C, Mourad M, Squifflet JP, Malaise J, Lerut J, Reding R, Borghgraef P, Vanbinst R, Wallemacq PE.
    Transplant Proc; 2005 Apr 01; 37(6):2890-1. PubMed ID: 16182845
    [Abstract] [Full Text] [Related]

  • 19. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
    Wallemacq P, Goffinet JS, O'Morchoe S, Rosiere T, Maine GT, Labalette M, Aimo G, Dickson D, Schmidt E, Schwinzer R, Schmid RW.
    Ther Drug Monit; 2009 Apr 01; 31(2):198-204. PubMed ID: 19258928
    [Abstract] [Full Text] [Related]

  • 20. High-performance liquid chromatography versus immunoassay for the measurement of sirolimus: comparison of two methods.
    Zochowska D, Bartłomiejczyk I, Kamińska A, Senatorski G, Paczek L.
    Transplant Proc; 2006 Apr 01; 38(1):78-80. PubMed ID: 16504669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.